Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 13.38
-0.47 (-3.39%)
Aug 14, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 278.72 million as of August 14, 2026. Its market cap has increased by 187.44% in one year.
Market Cap
278.72M
Enterprise Value
190.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.38
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 278.72M, an increase of 373.76%. That is a compound annual growth rate of 36.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 278.72M | 127.65% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.05B |
| Eupraxia Pharmaceuticals | 608.85M |
| Helix BioPharma | 137.48M |
| Eastwood Bio-Medical Canada | 106.77M |
| ME Therapeutics Holdings | 75.97M |
| NurExone Biologic | 44.67M |
| Sona Nanotech | 44.21M |
| MedMira | 42.10M |